APELYNE Trademark

Trademark Overview

On Monday, October 3, 2022, a trademark application was filed for APELYNE with the United States Patent and Trademark Office. The USPTO has given the APELYNE trademark a serial number of 97617461. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 7, 2024. This trademark is owned by Gorilla Mind LLC. The APELYNE trademark is filed in the Pharmaceutical Products category with the following description:

Appetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Pharmaceutical preparations, namely, appetite suppressants
apelyne

General Information

Serial Number97617461
Word MarkAPELYNE
Filing DateMonday, October 3, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesAppetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Pharmaceutical preparations, namely, appetite suppressants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGorilla Mind LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBoise, ID 83704
Party NameGorilla Mind LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoise, ID 83714

Trademark Events

Event DateEvent Description
Wednesday, June 7, 2023NON-FINAL ACTION WRITTEN
Thursday, October 6, 2022NEW APPLICATION ENTERED
Wednesday, October 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 29, 2023ASSIGNED TO EXAMINER
Wednesday, June 7, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 7, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 22, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, December 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

apelyne appetite suppressants preparations namely pharmaceutical medical suppressant pills purposes